Hans Clevers
Dutch molecular genetics and stem cell researcher / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Hans Clevers?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
This article is about a Dutch molecular genetics and stem cell researcher. For the purported horse mathematician, see Clever Hans.
Johannes (Hans) Carolus Clevers (born 27 March 1957)[2][3] is a Dutch molecular geneticist, cell biologist and stem cell researcher. He became the Head of Pharma, Research and Early Development, and a member of the Corporate Executive Committee, of the Swiss healthcare company Roche in 2022.[7][8] Previously, he headed a research group at the Hubrecht Institute for Developmental Biology and Stem Cell Research[9] and at the Princess Máxima Center [nl];[10] he remained as an advisor and guest scientist or visiting researcher to both groups.[7] He is also a Professor in Molecular Genetics at the University of Utrecht.[8]
Quick Facts Born, Nationality ...
Hans Clevers | |
---|---|
Born | Johannes Carolus Clevers[1] (1957-03-27) 27 March 1957 (age 67)[2][3][4] |
Nationality | Dutch |
Alma mater | University of Utrecht |
Known for | Organoid generation and application |
Spouse | Eefke Petersen[5] |
Children | 2[2] |
Awards | Louis-Jeantet Prize for Medicine Breakthrough Prize in Life Sciences Dr A. H. Heineken Prize for Medicine Körber European Science Prize |
Scientific career | |
Fields | Molecular genetics Cell biology |
Institutions | Roche Princess Máxima Center [nl] University Medical Center Utrecht Hubrecht Institute for Developmental Biology and Stem Cell Research Utrecht University Dana–Farber Cancer Institute |
Thesis | Early events in lymphocyte activation (1985) |
Doctoral advisor | Rudy Ballieux[6] |
Close